Skip to Content
Merck
  • Identification of point mutations in clinical Staphylococcus aureus strains that produce small-colony variants auxotrophic for menadione.

Identification of point mutations in clinical Staphylococcus aureus strains that produce small-colony variants auxotrophic for menadione.

Infection and immunity (2014-01-24)
Melissa A Dean, Randall J Olsen, S Wesley Long, Adriana E Rosato, James M Musser
ABSTRACT

Staphylococcus aureus small-colony variants (SCVs) are implicated in chronic and relapsing infections that are difficult to diagnose and treat. Despite many years of study, the underlying molecular mechanisms and virulence effect of the small-colony phenotype remain incompletely understood. We sequenced the genomes of five S. aureus SCV strains recovered from human patients and discovered previously unidentified nonsynonymous point mutations in three genes encoding proteins in the menadione biosynthesis pathway. Analysis of genetic revertants and complementation with wild-type alleles confirmed that these mutations caused the SCV phenotype and decreased virulence for mice.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Menadione sodium bisulfite, ≥95% (TLC)
Sigma-Aldrich
Menadione sodium bisulfite, BioReagent, suitable for cell culture, ≥95% (TLC)
Menadione, European Pharmacopoeia (EP) Reference Standard
Supelco
Menadione (K3), analytical standard
Sigma-Aldrich
Menadione, crystalline
Sigma-Aldrich
Menadione, meets USP testing specifications
USP
Menadione, United States Pharmacopeia (USP) Reference Standard
Supelco
Menadione, Pharmaceutical Secondary Standard; Certified Reference Material